摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-methylene-1,6-dithiacyclooctane | 180268-13-7

中文名称
——
中文别名
——
英文名称
3-methylene-1,6-dithiacyclooctane
英文别名
3-Methylidene-1,5-dithiocane
3-methylene-1,6-dithiacyclooctane化学式
CAS
180268-13-7
化学式
C7H12S2
mdl
——
分子量
160.304
InChiKey
HDXJAGRAUAFNMQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    50.6
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    1,3-丙二硫醇3-氯-2-氯甲基丙烯 以35%的产率得到3-methylene-1,6-dithiacyclooctane
    参考文献:
    名称:
    Polymerisable monomers and polymers
    摘要:
    本发明涉及具有以下公式化合物的制备方法:聚合物、共聚物或包含它们或它们作为自由基聚合的单体或共单体的块共聚物,以及在制造粘合剂、牙科复合材料或光学镜头中的用途。
    公开号:
    US06344556B1
点击查看最新优质反应信息

文献信息

  • Dental materials based on multicyclic allyl sulphides
    申请人:Angermann Jorg
    公开号:US20070203256A1
    公开(公告)日:2007-08-30
    Dental materials and associated methods are described based on multicyclic allyl sulphides with general Formula (I): in which R 1 is H or a C 1 -C 10 alkyl radical; R 2 is H or a C 1 -C 10 alkyl radical; R 3 is absent or is a C 1 -C 20 alkylene radical which can be interrupted by O or S, a cycloaliphatic C 4 -C 12 radical, a bicyclic C 6 -C 12 radical, a C 6 -C 14 arylene or C 7 -C 20 alkylene arylene radical; R 4 is an n-times substituted aliphatic C 2 to C 20 hydrocarbon radical which can be interrupted by O or S, a cycloaliphatic C 4 -C 12 radical, an aromatic C 6 -C 14 radical, an aliphatic-aromatic C 7 -C 20 radical or a heterocyclic radical which can contain 4 to 20 carbon atoms and 1 to 6 heteroatoms which are selected from N, O, P and/or S atoms, or which is formed exclusively by these heteroatoms; R 5 is absent or is a C 1 -C 10 alkylene radical; X is absent or is O, S, —O—CO— or —O—CO—NH—; Y is absent or is O, S, —O—CO— or —O—CO—NH—; m is 0 or 1 and n is an integer from 3 to 6.
    基于多环烯丙基硫化物的牙科材料及相关方法被描述,其具有通式(I): 其中,R1为氢或C1-C10烷基基团;R2为氢或C1-C10烷基基团;R3为不存在或者是可被O或S中断的C1-C20烷基基团,环状脂肪族C4-C12基团,双环C6-C12基团,C6-C14芳基烷基或C7-C20烷基芳基基团;R4为n次取代的C2到C20脂肪族碳氢基团,可被O或S中断的环状脂肪族C4-C12基团,芳香族C6-C14基团,脂肪族-芳香族C7-C20基团或含有4到20个碳原子和1到6个异原子(选择自N、O、P和/或S原子)的杂环基团,或者仅由这些异原子组成;R5不存在或为C1-C10烷基基团;X不存在或为O、S、—O—CO—或—O—CO—NH—;Y不存在或为O、S、—O—CO—或—O—CO—NH—;m为0或1,n为3到6的整数。
  • Degradable polymers
    申请人:Matyjaszewski Krzysztof
    公开号:US20070155926A1
    公开(公告)日:2007-07-05
    Polymers comprising a polymer backbone comprising one or more degradable units are described. The polymer may additionally comprise two or more polymer segments comprising radically (co)polymerizable vinyl monomer units. The degradable units may be independently selected from, but not limited to, at least one of hydrodegradable, photodegradable and biodegradable units between the polymer segments and dispersed along the polymer backbone. The degradable units may be derived from one or more monomers comprising a heterocyclic ring that is capable of undergoing radical ring opening polymerization, a coupling agent, or from a polymerization initiator, radically polymerizable monomers, as well as other reactive sources. Embodiments of the degradable polymer of claim are capable of degrading by at least one of a hydrodegradation, photodegradation or biodegradation mechanisms to form at least one of telechelic oligomer and telechelic polymeric fragments of the polymer. The degradable polymer may be able to degrade into polymer fragments having a molecular weight distribution of less than 5, or in certain applications it may be preferable for embodiments of the polymer to be capable of forming polymer fragments having a molecular weight distribution of the polymer fragments less than 3.0 or even less than 2.5. Embodiments of the present invention also include methods of producing degradable polymers.
    本发明涉及一种聚合物,其聚合骨架包含一个或多个可降解单元。该聚合物可能还包括两个或更多聚合物片段,其中包括自由基(共)聚合性乙烯单体单元。可降解单元可以独立选择,但不限于,在聚合物片段之间和沿聚合物骨架分散的至少一种水解降解、光降解和生物降解单元。可降解单元可以来源于一个或多个单体,包括能够经历自由基开环聚合的杂环环、偶联剂或聚合引发剂、自由基聚合性单体以及其他反应源。该可降解聚合物的实施例能够通过至少一种水解降解、光降解或生物降解机制降解,形成聚合物的末端寡聚物和末端聚合物片段。该可降解聚合物可以降解成分子量分布小于5的聚合物片段,或在某些应用中,最好是实施例能够形成分子量分布小于3.0甚至小于2.5的聚合物片段。本发明的实施例还包括制备可降解聚合物的方法。
  • CURABLE RESIN COMPOSITION FOR CEMENTED LENSES, IMAGE PICK-UP LENS, AND PROCESS FOR PRODUCITON OF IMAGE PICK-UP LENS
    申请人:FUJIFILM Corporation
    公开号:EP2412734A1
    公开(公告)日:2012-02-01
    A curable resin composition for a cemented lens capable of manufacturing a cemented lens excellent in heat resistance in reflowing treatment at a temperature of 260°C or higher and adhesion between lenses, and capable of reducing manufacturing costs of lenses and capable of lightening lenses, is provided. The curable resin composition for a cemented lens includes: (a) a compound represented by the following formula (I); and (b) a radical polymerization initiator. wherein R1 represents a hydrogen atom or an alkyl group; and Z1 represents a cyclic structure together with two carbon atoms and a sulfur atom.
    本发明提供了一种用于制造在 260°C 或更高温度下进行回流处理时具有优异耐热性和镜片间附着力的固结镜片的固化树脂组合物,该组合物能够降低镜片的制造成本并使镜片轻量化。 用于粘接镜片的可固化树脂组合物包括 (a) 下式(I)所代表的化合物;和 (b) 自由基聚合引发剂。 其中 R1 代表氢原子或烷基;Z1 代表由两个碳原子和一个硫原子组成的环状结构。
  • Secondary coating composition for optical fibers
    申请人:——
    公开号:US20030113091A1
    公开(公告)日:2003-06-19
    The present invention relates to a composition for coating optical fibers that includes a UV curable coating composition. The composition includes at least one component having at least one heterocyclic moiety capable of undergoing ring opening polymerization. The composition may also include at least one acrylate functional end group. The acrylate functional group may be on the same component as the heterocyclic moiety or on a second component. The cured composition has a Young's Modulus of at least about 100 MPa.
    本发明涉及一种用于涂覆光纤的组合物,其中包括一种紫外线固化涂层组合物。该组合物包括至少一种具有至少一个杂环分子的组分,该杂环分子能够进行开环聚合。该组合物还可包括至少一个丙烯酸酯官能团。丙烯酸酯官能团可以与杂环分子位于同一组分上,也可以位于第二组分上。固化组合物的杨氏模量至少约为 100 兆帕。
  • Dentalmaterialien auf der Basis von multicyclischen Allylsulfiden
    申请人:Ivoclar Vivadent AG
    公开号:EP1825843B1
    公开(公告)日:2009-06-10
查看更多

同类化合物

伊莫拉明 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-5'-苄氧基卡维地洛 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪) (3Z)-3-(1H-咪唑-5-基亚甲基)-5-甲氧基-1H-吲哚-2-酮 (3Z)-3-[[[4-(二甲基氨基)苯基]亚甲基]-1H-吲哚-2-酮 (3S,4R)-3-氟四氢-2H-吡喃-4-胺 (3R)-(-)-3-(1-甲基吲哚-3-基)丁酸甲酯 (3-氯-4,5-二氢-1,2-恶唑-5-基)(1,3-二氧代-1,3-二氢-2H-异吲哚-2-基)乙酸 (2S,4aR,5S,8R,8aR)-8-乙基-4a,5-二羟基-六氢-2H-2,5-环氧色素-4(3H)-酮 (2S)-6-氟-3,4-二氢-4-氧代-2H-1-苯并吡喃-2-甲酸 (2S)-4-[7-(8-氯-1-萘)-5,6,7,8-四氢-2-[[((2S)-1-甲基-2-吡咯烷基]甲氧基]吡啶基[3,4-d]嘧啶-4-基]-1-(2-氟-1-氧代-2-丙烯-1-基)-2-哌Chemicalbook嗪乙腈;2-((S)-4-(7-(8-氯萘-1-基)-2-((((S)-1- (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇